Name: British Patient Capital
Headquarters: Sheffield, UK
AUM: £3.08 billion ($3.8 billion; €3.5 billion)
British Patient Capital announced a $26.7 million commitment to Kindred Capital’s third fund, which also recently announced its final close on $130 million.
The fund Kindred Capital III invests into mission-driven, founder-led technology companies at the early venture stage.
British Patient Capital tends to make commitments to private equity funds that use growth equity or venture capital strategies across Europe. This can be seen in the table below, which shows British Patient Capital’s five most recent commitments.
Platinum subscribers may click here for the investor’s full profile, including key contacts, allocation strategy and fund investments.